Free Trial
→ Ex-Hedge Fund Manager Uncovers $100 Trillion Land Shift (From Stansberry Research) (Ad) Free AMPX Stock Alerts

Amprius Technologies (AMPX) Financials

Amprius Technologies logo
$6.36 -0.57 (-8.23%)
Closing price 08/1/2025 03:59 PM Eastern
Extended Trading
$6.80 +0.44 (+6.84%)
As of 08/1/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for Amprius Technologies

Annual Income Statements for Amprius Technologies

This table shows Amprius Technologies' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2021 2022 2023 2024
Period end date 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders		 -9.90 -17 -37 -45
Consolidated Net Income / (Loss)		 -9.90 -17 -37 -45
Net Income / (Loss) Continuing Operations		 -9.90 -17 -37 -45
Total Pre-Tax Income 		-9.90 -17 -37 -45
Total Operating Income		 -11 -18 -39 -46
Total Gross Profit		 -4.33 -5.65 -15 -18
Total Revenue		 2.77 4.41 9.05 24
Operating Revenue		 2.77 4.41 9.05 24
Total Cost of Revenue		 7.10 10 24 42
Operating Cost of Revenue		 7.10 10 24 42
Total Operating Expenses		 6.29 12 24 28
Selling, General & Admin Expense		 4.84 10 20 19
Research & Development Expense		 1.45 2.03 3.68 7.34
Other Special Charges / (Income)		 - - 0.00 1.86
Total Other Income / (Expense), net		 0.73 0.71 1.93 1.59
Interest & Investment Income		 -0.02 0.71 2.51 1.59
Other Income / (Expense), net		 - - -0.58 0.00
Basic Earnings per Share		 ($0.15) ($0.24) ($0.43) ($0.45)
Weighted Average Basic Shares Outstanding		 65.76M 71.34M 86.20M 101.87M
Diluted Earnings per Share		 ($0.15) ($0.24) ($0.43) ($0.45)
Weighted Average Diluted Shares Outstanding		 65.76M 71.34M 86.20M 101.87M
Weighted Average Basic & Diluted Shares Outstanding		 - 84.63M 91.60M 117.93M

Quarterly Income Statements for Amprius Technologies

This table shows Amprius Technologies' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 -4.24 -6.06 -9.10 -9.45 -8.49 -9.73 -9.89 -13 -11 -11 -9.37
Consolidated Net Income / (Loss)		 -4.24 -6.06 -9.10 -9.45 -8.49 -9.73 -9.89 -13 -11 -11 -9.37
Net Income / (Loss) Continuing Operations		 -4.24 -6.06 -9.10 -9.45 -8.49 -9.73 -9.89 -13 -11 -11 -9.37
Total Pre-Tax Income 		-4.24 -6.06 -9.10 -9.45 -8.49 -9.73 -9.89 -13 -11 -11 -9.37
Total Operating Income		 -4.32 -6.65 -9.75 -10 -9.13 -9.74 -10 -13 -11 -12 -9.67
Total Gross Profit		 -1.51 -1.74 -3.52 -3.03 -4.25 -3.88 -4.45 -6.53 -5.10 -2.25 -2.36
Total Revenue		 0.82 0.79 0.68 1.63 2.80 3.94 2.34 3.35 7.86 11 11
Operating Revenue		 0.82 0.79 0.68 1.63 2.80 3.94 2.34 3.35 7.86 11 11
Total Cost of Revenue		 2.33 2.53 4.20 4.66 7.05 7.82 6.78 9.88 13 13 14
Operating Cost of Revenue		 2.33 2.53 4.20 4.66 7.05 7.82 6.78 9.88 13 13 14
Total Operating Expenses		 2.81 4.91 6.23 7.05 4.88 5.87 5.87 6.40 6.15 9.51 7.31
Selling, General & Admin Expense		 2.32 4.22 5.43 6.28 4.07 4.58 4.29 4.74 4.34 5.36 5.31
Research & Development Expense		 0.49 0.69 0.80 0.77 0.82 1.29 1.58 1.66 1.82 2.28 2.00
Total Other Income / (Expense), net		 0.08 0.59 0.65 0.64 0.64 0.01 0.43 0.42 0.40 0.34 0.30
Basic Earnings per Share		 ($0.06) ($0.08) ($0.11) ($0.11) ($0.10) ($0.11) ($0.11) ($0.13) ($0.10) ($0.11) ($0.08)
Weighted Average Basic Shares Outstanding		 69.01M 71.34M 84.65M 85.22M 86.35M 86.20M 90.03M 97.05M 110.41M 101.87M 117.97M
Diluted Earnings per Share		 ($0.06) ($0.08) ($0.11) ($0.11) ($0.10) ($0.11) ($0.11) ($0.13) ($0.10) ($0.11) ($0.08)
Weighted Average Diluted Shares Outstanding		 69.01M 71.34M 84.65M 85.22M 86.35M 86.20M 90.03M 97.05M 110.41M 101.87M 117.97M
Weighted Average Basic & Diluted Shares Outstanding		 84.47M 84.63M 84.97M 86.27M 88.40M 91.60M 94.47M 111.05M 105.84M 117.93M 120.55M

Annual Cash Flow Statements for Amprius Technologies

This table details how cash moves in and out of Amprius Technologies' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2021 2022 2023 2024
Period end date 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Change in Cash & Equivalents		 11 58 -24 11
Net Cash From Operating Activities		 -8.02 -14 -26 -33
Net Cash From Continuing Operating Activities		 -8.02 -14 -26 -33
Net Income / (Loss) Continuing Operations		 -9.90 -17 -37 -45
Consolidated Net Income / (Loss)		 -9.90 -17 -37 -45
Depreciation Expense		 1.44 1.54 1.81 3.81
Amortization Expense		 0.55 1.59 3.06 6.39
Non-Cash Adjustments To Reconcile Net Income		 1.89 3.27 5.61 9.21
Changes in Operating Assets and Liabilities, net		 -2.00 -2.94 0.75 -8.08
Net Cash From Investing Activities		 -0.61 -1.48 -18 -3.21
Net Cash From Continuing Investing Activities		 -0.61 -1.48 -18 -3.21
Purchase of Property, Plant & Equipment		 -0.61 -1.48 -18 -3.21
Net Cash From Financing Activities		 20 74 19 47
Net Cash From Continuing Financing Activities		 20 74 19 47
Repurchase of Common Equity		 0.00 -0.33 -0.60 -0.76
Issuance of Common Equity		 0.00 78 19 33
Other Financing Activities, net		 20 -3.93 0.31 14

Quarterly Cash Flow Statements for Amprius Technologies

This table details how cash moves in and out of Amprius Technologies' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025
Net Change in Cash & Equivalents		 69 -4.38 -5.51 0.82 -12 -7.64 -5.52 7.40 -11 20 -6.53
Net Cash From Operating Activities		 -2.69 -5.70 -6.49 -5.58 -8.68 -4.80 -9.78 -7.96 -9.53 -6.09 -14
Net Cash From Continuing Operating Activities		 -2.69 -5.70 -6.49 -5.58 -8.68 -4.80 -9.78 -7.96 -9.53 -6.09 -14
Net Income / (Loss) Continuing Operations		 -4.24 -6.06 -9.10 -9.45 -8.49 -9.73 -9.89 -13 -11 -11 -9.37
Consolidated Net Income / (Loss)		 -4.24 -6.06 -9.10 -9.45 -8.49 -9.73 -9.89 -13 -11 -11 -9.37
Depreciation Expense		 0.39 0.40 0.42 0.44 0.46 0.49 1.02 1.04 0.86 0.89 0.94
Amortization Expense		 0.33 - 0.34 0.07 1.48 1.18 1.29 - 5.10 1.29 1.29
Non-Cash Adjustments To Reconcile Net Income		 0.91 0.73 0.73 1.43 0.61 2.84 1.25 3.23 -0.85 4.30 2.10
Changes in Operating Assets and Liabilities, net		 -0.09 -0.77 1.13 1.93 -2.74 0.43 -3.44 0.30 -3.80 -1.14 -9.08
Net Cash From Investing Activities		 -0.55 -0.73 -1.14 -1.73 -8.93 -5.75 -3.90 -1.61 -1.33 3.63 -0.91
Net Cash From Continuing Investing Activities		 -0.55 -0.73 -1.14 -1.73 -8.93 -5.75 -3.90 -1.61 -1.33 3.63 -0.91
Purchase of Property, Plant & Equipment		 -0.55 -0.73 -1.14 -1.73 -8.93 -5.75 -3.90 -1.61 -1.33 3.63 -0.91
Net Cash From Financing Activities		 72 2.05 2.12 8.13 6.00 2.92 8.16 17 -0.54 23 8.51
Net Cash From Continuing Financing Activities		 72 2.05 2.12 8.13 6.00 2.92 8.16 17 -0.54 23 8.51
Issuance of Common Equity		 78 - 2.39 8.12 6.04 2.92 8.13 2.73 - 23 8.46
Other Financing Activities, net		 -6.05 2.35 0.00 0.00 0.11 0.20 0.03 14 - 0.01 0.05
Effect of Exchange Rate Changes		 - - - - - - 0.00 - - - -0.00

Annual Balance Sheets for Amprius Technologies

This table presents Amprius Technologies' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2021 2022 2023 2024
Period end date 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Total Assets		 19 83 108 121
Total Current Assets		 14 75 51 69
Cash & Equivalents		 11 70 46 55
Accounts Receivable		 0.26 0.69 1.27 5.58
Inventories, net		 0.50 0.50 0.73 6.57
Prepaid Expenses		 0.16 2.39 1.99 1.45
Plant, Property, & Equipment, net		 4.21 4.24 22 17
Total Noncurrent Assets		 0.14 3.76 35 35
Other Noncurrent Operating Assets		 0.14 3.76 35 35
Total Liabilities & Shareholders' Equity		 19 83 108 121
Total Liabilities		 4.67 10 48 52
Total Current Liabilities		 4.17 6.92 13 17
Accounts Payable		 1.81 3.74 8.94 12
Current Deferred Revenue		 2.36 2.66 3.43 1.64
Other Current Liabilities		 0.00 0.52 1.09 3.32
Total Noncurrent Liabilities		 0.50 3.22 34 34
Other Noncurrent Operating Liabilities		 0.00 2.50 34 34
Commitments & Contingencies		 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 14 73 60 69
Total Preferred & Common Equity		 14 73 60 69
Preferred Stock		 - 0.00 0.00 0.00
Total Common Equity		 14 73 60 69
Common Stock		 89 166 189 244
Retained Earnings		 -75 -93 -130 -174
Accumulated Other Comprehensive Income / (Loss)		 - - - 0.00

Quarterly Balance Sheets for Amprius Technologies

This table presents Amprius Technologies' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025
Period end date 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025
Total Assets		 87 84 87 87 105 113 104 118
Total Current Assets		 78 70 71 61 46 53 45 66
Cash & Equivalents		 74 64 65 53 39 46 35 48
Accounts Receivable		 0.78 0.56 1.13 1.89 1.44 1.74 4.59 10
Inventories, net		 0.50 0.85 0.50 0.49 0.86 1.53 2.66 4.00
Prepaid Expenses		 2.32 1.84 1.48 2.74 3.35 2.17 2.64 3.31
Plant, Property, & Equipment, net		 3.82 4.95 6.90 17 23 24 24 18
Total Noncurrent Assets		 4.86 9.10 9.03 8.55 36 36 35 34
Other Noncurrent Operating Assets		 4.86 9.10 9.03 8.55 36 36 35 34
Total Liabilities & Shareholders' Equity		 87 84 87 87 105 113 104 118
Total Liabilities		 11 17 20 21 45 48 48 48
Total Current Liabilities		 6.14 8.88 12 14 9.76 13 13 14
Accounts Payable		 4.82 4.69 7.74 9.23 5.42 7.76 9.13 8.55
Current Deferred Revenue		 0.80 3.14 3.20 3.57 3.24 3.15 1.82 1.78
Other Current Liabilities		 0.52 1.06 1.07 1.08 1.10 1.92 2.05 3.64
Total Noncurrent Liabilities		 4.36 8.03 7.94 6.98 35 35 35 34
Other Noncurrent Operating Liabilities		 2.58 7.13 7.00 6.87 35 35 35 34
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 76 67 67 66 60 65 56 70
Total Preferred & Common Equity		 76 67 67 66 60 65 56 70
Preferred Stock		 - - 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 76 67 67 66 60 65 56 70
Common Stock		 163 169 178 186 199 217 219 254
Retained Earnings		 -87 -102 -111 -120 -140 -152 -163 -184
Accumulated Other Comprehensive Income / (Loss)		 - - - - - - - -0.00

Annual Metrics And Ratios for Amprius Technologies

This table displays calculated financial ratios and metrics derived from Amprius Technologies' official financial filings.

Metric 2021 2022 2023 2024
Period end date 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Growth Metrics		 - - - -
Revenue Growth		 0.00% 59.05% 105.33% 166.95%
EBITDA Growth		 0.00% -72.77% -130.79% -4.76%
EBIT Growth		 0.00% -69.83% -117.78% -17.75%
NOPAT Growth		 0.00% -69.83% -114.56% -19.51%
Net Income Growth		 0.00% -75.14% -112.19% -21.47%
EPS Growth		 0.00% -60.00% -79.17% -4.65%
Operating Cash Flow Growth		 0.00% -73.18% -84.07% -30.52%
Free Cash Flow Firm Growth		 0.00% 0.00% -178.00% 13.59%
Invested Capital Growth		 0.00% 40.86% 320.71% 1.98%
Revenue Q/Q Growth		 0.00% 0.00% 53.41% 38.26%
EBITDA Q/Q Growth		 0.00% 0.00% -7.54% -4.34%
EBIT Q/Q Growth		 0.00% 0.00% -10.33% -4.55%
NOPAT Q/Q Growth		 0.00% 0.00% -8.70% -4.55%
Net Income Q/Q Growth		 0.00% 0.00% -11.11% -3.92%
EPS Q/Q Growth		 0.00% 0.00% -7.50% 0.00%
Operating Cash Flow Q/Q Growth		 0.00% -40.32% 3.40% -4.01%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% 17.45%
Invested Capital Q/Q Growth		 0.00% 0.00% 13.58% -31.67%
Profitability Metrics		 - - - -
Gross Margin		 -156.17% -128.24% -162.11% -75.85%
EBITDA Margin		 -311.47% -338.33% -380.28% -149.23%
Operating Margin		 -383.23% -409.19% -427.58% -191.43%
EBIT Margin		 -383.23% -409.19% -434.00% -191.43%
Profit (Net Income) Margin		 -357.00% -393.11% -406.23% -184.84%
Tax Burden Percent		 100.00% 100.00% 100.00% 100.00%
Interest Burden Percent		 93.16% 96.07% 93.60% 96.56%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 -313.89% -442.65% -311.88% -228.41%
ROIC Less NNEP Spread (ROIC-NNEP)		 -292.48% -431.06% -295.11% -204.05%
Return on Net Nonoperating Assets (RNNOA)		 242.48% 402.75% 256.51% 159.29%
Return on Equity (ROE)		 -71.41% -39.89% -55.37% -69.11%
Cash Return on Invested Capital (CROIC)		 0.00% -476.58% -435.06% -230.37%
Operating Return on Assets (OROA)		 -57.34% -35.48% -41.16% -40.43%
Return on Assets (ROA)		 -53.41% -34.09% -38.53% -39.04%
Return on Common Equity (ROCE)		 -71.41% -39.89% -55.37% -69.11%
Return on Equity Simple (ROE_SIMPLE)		 -71.41% -23.73% -61.50% -64.30%
Net Operating Profit after Tax (NOPAT)		 -7.44 -13 -27 -32
NOPAT Margin		 -268.26% -286.43% -299.31% -134.00%
Net Nonoperating Expense Percent (NNEP)		 -21.41% -11.59% -16.77% -24.35%
Return On Investment Capital (ROIC_SIMPLE)		 - - -45.31% -46.61%
Cost of Revenue to Revenue		 256.17% 228.24% 262.11% 175.85%
SG&A Expenses to Revenue		 174.75% 234.97% 224.85% 77.49%
R&D to Revenue		 52.31% 45.97% 40.62% 30.39%
Operating Expenses to Revenue		 227.06% 280.95% 265.47% 115.58%
Earnings before Interest and Taxes (EBIT)		 -11 -18 -39 -46
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -8.63 -15 -34 -36
Valuation Ratios		 - - - -
Price to Book Value (P/BV)		 14.43 9.17 7.82 4.27
Price to Tangible Book Value (P/TBV)		 14.43 9.17 7.82 4.27
Price to Revenue (P/Rev)		 72.15 151.92 51.65 12.26
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 79.57 179.84 30.05 16.85
Enterprise Value to Revenue (EV/Rev)		 68.01 136.12 46.60 9.98
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - -
Debt to Equity		 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00
Financial Leverage		 -0.83 -0.93 -0.87 -0.78
Leverage Ratio		 1.34 1.17 1.44 1.77
Compound Leverage Factor		 1.25 1.12 1.35 1.71
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA		 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00
Altman Z-Score		 18.91 38.40 3.46 0.88
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - -
Current Ratio		 3.40 10.87 3.75 4.00
Quick Ratio		 2.82 10.18 3.49 3.53
Cash Flow Metrics		 - - - -
Free Cash Flow to Firm (FCFF)		 0.00 -14 -38 -33
Operating Cash Flow to CapEx		 -1,316.26% -937.34% -145.60% -1,039.98%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - -
Asset Turnover		 0.15 0.09 0.09 0.21
Accounts Receivable Turnover		 10.58 9.30 9.28 7.06
Inventory Turnover		 14.20 20.13 38.58 11.64
Fixed Asset Turnover		 0.66 1.04 0.70 1.23
Accounts Payable Turnover		 3.93 3.63 3.75 4.01
Days Sales Outstanding (DSO)		 34.50 39.24 39.33 51.69
Days Inventory Outstanding (DIO)		 25.70 18.14 9.46 31.37
Days Payable Outstanding (DPO)		 92.78 100.49 97.45 91.00
Cash Conversion Cycle (CCC)		 -32.58 -43.11 -48.66 -7.95
Capital & Investment Metrics		 - - - -
Invested Capital		 2.37 3.34 14 14
Invested Capital Turnover		 1.17 1.55 1.04 1.70
Increase / (Decrease) in Invested Capital		 0.00 0.97 11 0.28
Enterprise Value (EV)		 189 600 422 241
Market Capitalization		 200 670 468 296
Book Value per Share		 $0.21 $0.86 $0.68 $0.66
Tangible Book Value per Share		 $0.21 $0.86 $0.68 $0.66
Total Capital		 14 73 60 69
Total Debt		 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00 0.00
Net Debt		 -11 -70 -46 -55
Capital Expenditures (CapEx)		 0.61 1.48 18 3.21
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -1.48 -1.44 -8.70 -3.60
Debt-free Net Working Capital (DFNWC)		 10 68 37 52
Net Working Capital (NWC)		 10 68 37 52
Net Nonoperating Expense (NNE)		 2.46 4.70 9.68 12
Net Nonoperating Obligations (NNO)		 -11 -70 -46 -55
Total Depreciation and Amortization (D&A)		 1.99 3.12 4.86 10
Debt-free, Cash-free Net Working Capital to Revenue		 -53.43% -32.66% -96.06% -14.90%
Debt-free Net Working Capital to Revenue		 361.04% 1,548.11% 409.42% 213.32%
Net Working Capital to Revenue		 361.04% 1,548.11% 409.42% 213.32%
Earnings Adjustments		 - - - -
Adjusted Basic Earnings per Share		 $0.00 ($0.24) ($0.43) ($0.45)
Adjusted Weighted Average Basic Shares Outstanding		 0.00 71.34M 86.20M 101.87M
Adjusted Diluted Earnings per Share		 $0.00 ($0.24) ($0.43) ($0.45)
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 71.34M 86.20M 101.87M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 84.63M 91.60M 117.93M
Normalized Net Operating Profit after Tax (NOPAT)		 -7.44 -13 -27 -31
Normalized NOPAT Margin		 -268.26% -286.43% -299.31% -128.61%
Pre Tax Income Margin		 -357.00% -393.11% -406.23% -184.84%
Debt Service Ratios		 - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00
Payout Ratios		 - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% -1.88% -1.63% -1.69%

Quarterly Metrics And Ratios for Amprius Technologies

This table displays calculated financial ratios and metrics derived from Amprius Technologies' official financial filings.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 147.27% 0.00% -67.82% 136.18% 242.89% 397.98% 244.04% 104.96% 180.74% 169.55% 383.05%
EBITDA Growth		 -14.70% 0.00% -592.23% -153.96% -99.83% -29.32% -3.37% -24.21% 26.48% -18.58% 7.16%
EBIT Growth		 -37.81% 0.00% -235.09% -142.32% -111.22% -46.59% -5.83% -28.26% -23.24% -20.67% 6.28%
NOPAT Growth		 -37.81% 0.00% -235.09% -142.32% -111.22% -46.59% -5.83% -28.26% -23.24% -20.67% 6.28%
Net Income Growth		 -35.12% 0.00% -216.26% -127.44% -100.09% -60.73% -8.61% -32.48% -27.77% -17.30% 5.21%
EPS Growth		 -20.00% 0.00% -175.00% -83.33% -66.67% -37.50% 0.00% -18.18% 0.00% 0.00% 27.27%
Operating Cash Flow Growth		 0.00% -233.41% -113.34% -127.97% -222.36% 15.76% -50.63% -42.56% -9.81% -26.77% -44.45%
Free Cash Flow Firm Growth		 0.00% 0.00% 0.00% 0.00% -216.79% 0.00% -112.85% -112.94% 0.49% 51.44% 68.90%
Invested Capital Growth		 0.00% 0.00% -98.62% -99.20% 462.07% 320.71% 633.50% 1,012.02% 69.53% 1.98% 5.21%
Revenue Q/Q Growth		 18.09% -2.94% -14.27% 140.35% 71.45% 40.96% -40.77% 43.19% 134.83% 35.34% 6.14%
EBITDA Q/Q Growth		 4.59% -73.65% -44.03% -6.42% 24.92% -12.38% -27.97% -27.89% 55.56% -81.25% 22.33%
EBIT Q/Q Growth		 -3.89% -53.76% -46.70% -3.40% 9.44% -6.71% -5.90% -25.32% 12.98% -4.49% 17.75%
NOPAT Q/Q Growth		 -3.89% -53.76% -46.70% -3.40% 9.44% -6.71% -5.90% -25.32% 12.98% -4.49% 17.75%
Net Income Q/Q Growth		 -2.17% -42.70% -50.30% -3.80% 10.12% -14.63% -1.56% -26.61% 13.32% -5.24% 17.93%
EPS Q/Q Growth		 0.00% -33.33% -37.50% 0.00% 9.09% -10.00% 0.00% -18.18% 23.08% -10.00% 27.27%
Operating Cash Flow Q/Q Growth		 -9.92% -111.66% -13.93% 14.00% -55.44% 44.69% -103.73% 18.61% -19.73% 36.14% -132.14%
Free Cash Flow Firm Q/Q Growth		 0.00% 100.00% 0.00% 2.39% -108.22% -5.86% -44.19% -3.12% 36.78% 48.34% 7.64%
Invested Capital Q/Q Growth		 -98.95% 51.75% -14.65% -41.01% 635.71% 13.58% 48.80% -10.57% 12.16% -31.67% 53.52%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 -185.05% -219.82% -517.97% -185.78% -151.82% -98.35% -190.28% -195.25% -64.94% -21.19% -20.92%
EBITDA Margin		 -440.93% -788.89% -1,325.33% -586.83% -256.97% -204.87% -398.20% -355.64% -67.29% -90.12% -65.95%
Operating Margin		 -529.78% -839.27% -1,436.08% -617.83% -326.34% -247.06% -441.74% -386.61% -143.26% -110.60% -85.71%
EBIT Margin		 -529.78% -839.27% -1,436.08% -617.83% -326.34% -247.06% -441.74% -386.61% -143.26% -110.60% -85.71%
Profit (Net Income) Margin		 -520.10% -764.65% -1,340.50% -578.92% -303.50% -246.81% -423.20% -374.20% -138.13% -107.40% -83.05%
Tax Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Interest Burden Percent		 98.17% 91.11% 93.34% 93.70% 93.00% 99.90% 95.80% 96.79% 96.42% 97.11% 96.90%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% -776.22% -28.63% -16.01% -185.18% -180.21% -279.02% -330.22% -105.24% -131.97% -92.69%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% -774.20% -21.81% -8.85% -181.88% -175.16% -273.86% -324.00% -98.51% -125.65% -86.74%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 738.83% 5.28% 2.12% 163.20% 152.25% 222.66% 273.95% 71.56% 98.09% 58.21%
Return on Equity (ROE)		 0.00% -37.39% -23.34% -13.89% -21.98% -27.96% -56.36% -56.27% -33.68% -33.88% -34.48%
Cash Return on Invested Capital (CROIC)		 0.00% -407.45% 0.00% 0.00% 0.00% -435.06% -383.65% -456.64% -237.54% -230.37% -154.05%
Operating Return on Assets (OROA)		 0.00% -72.77% -26.98% -15.17% -22.25% -23.43% -50.16% -48.17% -26.25% -23.36% -25.44%
Return on Assets (ROA)		 0.00% -66.30% -25.19% -14.21% -20.69% -23.41% -48.06% -46.63% -25.31% -22.68% -24.65%
Return on Common Equity (ROCE)		 0.00% -37.39% -3.89% -2.41% -21.98% -27.96% -56.36% -56.27% -33.68% -33.88% -34.48%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 0.00% -35.14% -43.26% -50.33% 0.00% -62.67% -62.38% -76.76% 0.00% -62.73%
Net Operating Profit after Tax (NOPAT)		 -3.03 -4.65 -6.83 -7.06 -6.39 -6.82 -7.22 -9.05 -7.88 -8.23 -6.77
NOPAT Margin		 -370.85% -587.49% -1,005.26% -432.48% -228.44% -172.94% -309.22% -270.62% -100.28% -77.42% -59.99%
Net Nonoperating Expense Percent (NNEP)		 -3.30% -2.01% -6.81% -7.16% -3.30% -5.05% -5.16% -6.22% -6.72% -6.32% -5.95%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - -11.41% - - - -11.85% -9.62%
Cost of Revenue to Revenue		 285.05% 319.82% 617.97% 285.78% 251.82% 198.35% 290.28% 295.25% 164.94% 121.19% 120.92%
SG&A Expenses to Revenue		 284.68% 532.32% 800.29% 384.74% 145.39% 116.00% 183.78% 141.67% 55.19% 50.41% 47.03%
R&D to Revenue		 60.05% 87.12% 117.82% 47.30% 29.13% 32.71% 67.68% 49.69% 23.13% 21.48% 17.75%
Operating Expenses to Revenue		 344.73% 619.44% 918.11% 432.05% 174.52% 148.71% 251.46% 191.36% 78.32% 89.41% 64.78%
Earnings before Interest and Taxes (EBIT)		 -4.32 -6.65 -9.75 -10 -9.13 -9.74 -10 -13 -11 -12 -9.67
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -3.60 -6.25 -9.00 -9.58 -7.19 -8.08 -9.30 -12 -5.29 -9.58 -7.44
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 3.99 9.17 11.00 9.15 6.22 7.82 4.05 1.84 2.20 4.27 4.49
Price to Tangible Book Value (P/TBV)		 3.99 9.17 11.00 9.15 6.22 7.82 4.05 1.84 2.20 4.27 4.49
Price to Revenue (P/Rev)		 0.00 151.92 247.52 155.68 69.30 51.65 22.66 9.66 7.05 12.26 9.54
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 104.26 179.84 236.29 324.46 28.77 30.05 9.75 3.94 4.21 16.85 12.18
Enterprise Value to Revenue (EV/Rev)		 0.00 136.12 225.97 139.09 60.25 46.60 19.02 5.92 5.05 9.98 8.08
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -0.97 -0.95 -0.24 -0.24 -0.90 -0.87 -0.81 -0.85 -0.73 -0.78 -0.67
Leverage Ratio		 1.14 1.17 1.15 1.15 1.22 1.44 1.49 1.51 1.57 1.77 1.71
Compound Leverage Factor		 1.12 1.07 1.07 1.07 1.14 1.44 1.42 1.46 1.51 1.72 1.66
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 0.00 38.85 24.97 17.02 10.20 4.37 1.58 -0.22 -0.48 1.82 2.31
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 83.33% 82.64% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 12.68 10.87 7.87 5.89 4.42 3.75 4.67 4.14 3.46 4.00 4.74
Quick Ratio		 12.16 10.18 7.29 5.51 3.98 3.49 4.15 3.76 3.05 3.53 4.21
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -5.23 0.00 197 201 -17 -18 -25 -26 -16 -8.51 -7.86
Operating Cash Flow to CapEx		 -486.80% -776.29% -569.47% -323.09% -97.17% -83.46% -251.00% -495.89% -714.85% 0.00% -1,547.21%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.00 0.09 0.02 0.02 0.07 0.09 0.11 0.12 0.18 0.21 0.30
Accounts Receivable Turnover		 0.00 9.30 0.00 0.00 4.42 9.28 10.73 8.66 5.40 7.06 5.59
Inventory Turnover		 0.00 20.13 0.00 0.00 37.25 38.58 30.90 31.06 23.76 11.64 20.31
Fixed Asset Turnover		 0.00 1.04 0.00 0.00 0.58 0.70 0.77 0.81 0.86 1.23 1.62
Accounts Payable Turnover		 0.00 3.63 4.67 3.53 2.62 3.75 5.21 4.07 4.08 4.01 7.07
Days Sales Outstanding (DSO)		 0.00 39.24 0.00 0.00 82.54 39.33 34.03 42.13 67.62 51.69 65.24
Days Inventory Outstanding (DIO)		 0.00 18.14 0.00 0.00 9.80 9.46 11.81 11.75 15.36 31.37 17.97
Days Payable Outstanding (DPO)		 0.00 100.49 78.18 103.33 139.07 97.45 70.12 89.71 89.49 91.00 51.65
Cash Conversion Cycle (CCC)		 0.00 -43.11 -78.18 -103.33 -46.73 -48.66 -24.28 -35.83 -6.51 -7.95 31.57
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 2.20 3.34 2.85 1.68 12 14 21 19 21 14 22
Invested Capital Turnover		 0.00 1.32 0.03 0.04 0.81 1.04 0.90 1.22 1.05 1.70 1.54
Increase / (Decrease) in Invested Capital		 2.20 0.00 -203 -208 10 11 18 17 8.59 0.28 1.09
Enterprise Value (EV)		 229 600 673 545 356 422 204 74 88 241 268
Market Capitalization		 303 670 737 610 409 468 243 120 123 296 316
Book Value per Share		 $2.31 $0.86 $0.79 $0.78 $0.76 $0.68 $0.65 $0.69 $0.50 $0.66 $0.60
Tangible Book Value per Share		 $2.31 $0.86 $0.79 $0.78 $0.76 $0.68 $0.65 $0.69 $0.50 $0.66 $0.60
Total Capital		 76 73 67 67 66 60 60 65 56 69 70
Total Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -74 -70 -64 -65 -53 -46 -39 -46 -35 -55 -48
Capital Expenditures (CapEx)		 0.55 0.73 1.14 1.73 8.93 5.75 3.90 1.61 1.33 -3.63 0.91
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -2.12 -1.44 -3.17 -6.32 -5.88 -8.70 -3.18 -6.23 -3.11 -3.60 3.75
Debt-free Net Working Capital (DFNWC)		 72 68 61 59 48 37 36 40 32 52 52
Net Working Capital (NWC)		 72 68 61 59 48 37 36 40 32 52 52
Net Nonoperating Expense (NNE)		 1.22 1.40 2.28 2.39 2.10 2.91 2.66 3.46 2.97 3.19 2.60
Net Nonoperating Obligations (NNO)		 -74 -70 -64 -65 -53 -46 -39 -46 -35 -55 -48
Total Depreciation and Amortization (D&A)		 0.73 0.40 0.75 0.51 1.94 1.66 1.02 1.04 5.97 2.18 2.23
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% -32.66% -106.38% -161.16% -99.59% -96.06% -29.73% -50.15% -17.76% -14.90% 11.31%
Debt-free Net Working Capital to Revenue		 0.00% 1,548.11% 2,048.99% 1,497.68% 805.27% 409.42% 334.84% 323.73% 182.72% 213.32% 157.52%
Net Working Capital to Revenue		 0.00% 1,548.11% 2,048.99% 1,497.68% 805.27% 409.42% 334.84% 323.73% 182.72% 213.32% 157.52%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.06) ($0.08) ($0.11) ($0.11) ($0.10) ($0.11) ($0.11) ($0.13) ($0.10) ($0.11) ($0.08)
Adjusted Weighted Average Basic Shares Outstanding		 69.01M 71.34M 84.65M 85.22M 86.35M 86.20M 90.03M 97.05M 110.41M 101.87M 117.97M
Adjusted Diluted Earnings per Share		 ($0.06) ($0.08) ($0.11) ($0.11) ($0.10) ($0.11) ($0.11) ($0.13) ($0.10) ($0.11) ($0.08)
Adjusted Weighted Average Diluted Shares Outstanding		 69.01M 71.34M 84.65M 85.22M 86.35M 86.20M 90.03M 97.05M 110.41M 101.87M 117.97M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 84.47M 84.63M 84.97M 86.27M 88.40M 91.60M 94.47M 111.05M 105.84M 117.93M 120.55M
Normalized Net Operating Profit after Tax (NOPAT)		 -3.03 -4.65 -6.83 -7.06 -6.39 -6.82 -7.22 -9.05 -7.88 -8.23 -6.77
Normalized NOPAT Margin		 -370.85% -587.49% -1,005.26% -432.48% -228.44% -172.94% -309.22% -270.62% -100.28% -77.42% -59.99%
Pre Tax Income Margin		 -520.10% -764.65% -1,340.50% -578.92% -303.50% -246.81% -423.20% -374.20% -138.13% -107.40% -83.05%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% -1.88% -2.52% -2.01% -2.14% -1.63% -0.89% -1.39% -2.21% -1.69% 0.00%

Key Financial Trends

Amprius Technologies (NYSE: AMPX) has experienced consistent revenue growth over the last several quarters, with operating revenue reaching $11.28 million in Q1 2025, up from $10.63 million in Q4 2024 and significantly higher than earlier periods. Despite this growth in revenue, the company continues to operate at a loss, with a consolidated net loss of $9.37 million in Q1 2025, which is an improvement compared to the $11.42 million loss in Q4 2024 but still indicative of ongoing profitability challenges.

The company’s cost structure remains high, with the operating cost of revenue exceeding total revenue in recent quarters, resulting in negative gross profit margins. For example, in Q1 2025, total cost of revenue was $13.65 million versus revenue of $11.28 million, producing a negative gross profit of $2.36 million. Operating expenses, including selling, general & administrative (SG&A) and research & development (R&D), further weigh on earnings.

On the balance sheet front, Amprius has maintained a strong cash position, with $48.4 million in cash and equivalents as of Q1 2025. This represents a decrease from $55.4 million in Q4 2024 but remains a comfortable liquidity buffer. Total assets have grown to $118.47 million, supported by increases in current assets and plant, property & equipment. Total liabilities are $48.08 million, with total shareholders' equity at about $70.4 million, indicating a reasonable capital structure given the stage of the company.

Cash flow statements show significant negative cash flow from operations in Q1 2025 (-$14.13 million), reflecting ongoing investment in growth and costs exceeding cash receipts from operations. Investing activities used $913,000, mainly for property, plant & equipment. Financing activities contributed positive cash flows totaling $8.51 million from the issuance of common equity, which helped offset operating and investing outflows.

  • Revenue growth to $11.28 million in Q1 2025, showing improving sales traction.
  • Strong cash position of $48.4 million supports operational needs and investments.
  • Equity financing provided $8.5 million in Q1 2025, enhancing liquidity.
  • Investment in plant, property, and equipment indicates commitment to future capacity and technology development.
  • Gross profit remains negative due to higher cost of revenue relative to sales.
  • Operating losses persist but showed some improvement compared to previous quarters.
  • Cash burn from operations remains substantial, requiring continuous financing or improved profitability.
  • Increase in total assets and equity reflects company growth and capital raises.
  • The company’s share count has modestly increased, somewhat diluting shareholders.
  • Continuous net losses exceeding $9 million per quarter highlight ongoing profitability challenges.
  • Negative operating cash flow (-$14.1 million in Q1 2025) indicates persistent cash burn.
  • Cost of revenue outpaces sales, resulting in sustained negative gross margins.
  • Rising operating expenses contribute to widening net losses despite revenue growth.
  • Reduction in cash and equivalents from Q4 2024 to Q1 2025 indicates resource consumption.

Summary: Amprius Technologies continues to experience top-line growth but struggles with profitability and high operating costs. The company’s strong cash reserves and recent equity financing provide a runway to support growth initiatives. However, sustained net losses and negative cash flow from operations highlight the need for improved cost management and operational scaling to achieve profitability. Investors should watch upcoming quarters for stabilization in margins and operating income, alongside continued revenue growth.

08/02/25 03:46 AMAI Generated. May Contain Errors.

Frequently Asked Questions About Amprius Technologies' Financials

When does Amprius Technologies' fiscal year end?

According to the most recent income statement we have on file, Amprius Technologies' financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Amprius Technologies' net income changed over the last 3 years?

Amprius Technologies' net income appears to be on an upward trend, with a most recent value of -$44.67 million in 2024, rising from -$9.90 million in 2021. The previous period was -$36.78 million in 2023. See Amprius Technologies' forecast for analyst expectations on what’s next for the company.

What is Amprius Technologies' operating income?
Amprius Technologies' total operating income in 2024 was -$46.26 million, based on the following breakdown:
  • Total Gross Profit: -$18.33 million
  • Total Operating Expenses: $27.93 million
How has Amprius Technologies' revenue changed over the last 3 years?

Over the last 3 years, Amprius Technologies' total revenue changed from $2.77 million in 2021 to $24.17 million in 2024, a change of 771.8%.

How much debt does Amprius Technologies have?

Amprius Technologies' total liabilities were at $51.65 million at the end of 2024, a 7.8% increase from 2023, and a 1,006.3% increase since 2021.

How much cash does Amprius Technologies have?

In the past 3 years, Amprius Technologies' cash and equivalents has ranged from $11.49 million in 2021 to $69.70 million in 2022, and is currently $55.16 million as of their latest financial filing in 2024.

How has Amprius Technologies' book value per share changed over the last 3 years?

Over the last 3 years, Amprius Technologies' book value per share changed from 0.21 in 2021 to 0.66 in 2024, a change of 211.5%.


Related Companies

This page (NYSE:AMPX) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners
Is Elon's empire crumbling?
The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...
Brownstone Research | Sponsored
Buffett to put 90% of his money in this one stock?
CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...
Altimetry | Sponsored
He Called Nvidia at $1.10. Now, He Says THIS Stock Will…
The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...
The Oxford Club | Sponsored
Digital Dollar Alert: Protect Your Wealth Before It’s Too Late
134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...
American Alternative | Sponsored
China just unlocked Nvidia’s AI chips—what that means for you
Tired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...
Timothy Sykes | Sponsored
REVEALED FREE: Our top 3 stocks to own in 2025 and beyond
Every time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...
Weiss Ratings | Sponsored
Why AMZN, GOOG, MSFT might destroy NVDA
Investing Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...
InvestorPlace | Sponsored
Your blueprint for crypto wealth
Mark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…
Crypto 101 Media | Sponsored